Agios Pharmaceuticals (AGIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -177,667 | -81,549 | -352,088 | -256,148 | -164,824 |
| Depreciation Amortization | -2,195 | -1,179 | 1,572 | 562 | -2,141 |
| Accounts receivable | -952 | -643 | -604 | 1,030 | -45 |
| Accounts payable and accrued liabilities | 268 | 1,430 | -8,733 | -5,201 | -6,837 |
| Other Working Capital | -18,860 | -28,985 | -19,057 | -24,657 | -21,955 |
| Other Operating Activity | 26,950 | 11,059 | 82,848 | 60,840 | 33,871 |
| Operating Cash Flow | $-172,456 | $-99,867 | $-296,062 | $-223,574 | $-161,931 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -259 | -101 | 326 | 560 | -246 |
| Purchase Of Investment | -348,604 | -244,059 | -417,930 | -327,490 | -232,486 |
| Sale Of Investment | 510,669 | 368,722 | 674,679 | 488,492 | 337,453 |
| Other Investing Activity | 0 | 0 | -17,500 | -17,500 | 0 |
| Investing Cash Flow | $161,806 | $124,562 | $239,575 | $144,062 | $104,721 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 6,963 | 5,864 | 5,433 | 4,586 | 2,704 |
| Financing Cash Flow | $6,963 | $5,864 | $5,433 | $4,586 | $2,704 |
| Beginning Cash Position | 88,205 | 88,205 | 139,259 | 139,259 | 139,259 |
| End Cash Position | 84,518 | 118,764 | 88,205 | 64,333 | 84,753 |
| Net Cash Flow | $-3,687 | $30,559 | $-51,054 | $-74,926 | $-54,506 |
| Free Cash Flow | |||||
| Operating Cash Flow | -172,456 | -99,867 | -296,062 | -223,574 | -161,931 |
| Capital Expenditure | -299 | -141 | -999 | -765 | -396 |
| Free Cash Flow | -172,755 | -100,008 | -297,061 | -224,339 | -162,327 |